Yogesh Moradiya1, Santosh B Murthy2, David E Newman-Toker2, Daniel F Hanley2, Wendy C Ziai2. 1. From the Division of Neurosciences Critical Care (Y.M., S.B.M., W.C.Z.), Department of Neurology (D.E.N.-T.), Division of Brain Injury Outcomes (D.F.H.), Johns Hopkins University School of Medicine, Baltimore, MD. yogeshmoradiyamd@gmail.com. 2. From the Division of Neurosciences Critical Care (Y.M., S.B.M., W.C.Z.), Department of Neurology (D.E.N.-T.), Division of Brain Injury Outcomes (D.F.H.), Johns Hopkins University School of Medicine, Baltimore, MD.
Abstract
BACKGROUND AND PURPOSE: Intraventricular thrombolysis (IVT) is a promising treatment in facilitating intraventricular clot resolution after intraventricular hemorrhage. We examined in-hospital outcomes and resource utilization after thrombolysis in patients with intraventricular hemorrhage requiring ventriculostomy in a real-world setting. METHODS: We identified adult patients with primary diagnosis of nontraumatic intracerebral hemorrhage requiring ventriculostomy from the Nationwide Inpatient Sample from 2002 to 2011. We compared demographic and hospital characteristics, comorbidities, inpatient outcomes, and resource utilization measures between patients treated with IVT and those managed with ventriculostomy, but without IVT. Population estimates were extrapolated using standard Nationwide Inpatient Sample weighting algorithms. RESULTS: We included 34 044 patients in the analysis, of whom 1133 (3.3%) received IVT. The thrombolysis group had significantly lower inpatient mortality (32.4% versus 41.6%; P=0.001) and it remained lower after controlling for baseline demographics, hospital characteristics, comorbidity, case severity, and withdrawal of care status (adjusted odds ratio, 0.670; 95% confidence interval, 0.520-0.865; P=0.002). There was a trend toward favorable discharge (home or rehabilitation) among the thrombolysis cohort (adjusted odds ratio, 1.335; 95% confidence interval, 0.983-1.812; P=0.064). The adjusted rates of bacterial meningitis and ventricular shunt placement were similar between groups. The thrombolysis group had longer length of stay and higher inflation-adjusted cost of care, but cost of care per day length of stay was similar to the non-IVT group. CONCLUSIONS: IVT for intracerebral hemorrhage requiring ventriculostomy resulted in lower inpatient mortality and a trend toward favorable discharge outcome with similar rates of inpatient complications compared with the non-IVT group.
BACKGROUND AND PURPOSE: Intraventricular thrombolysis (IVT) is a promising treatment in facilitating intraventricular clot resolution after intraventricular hemorrhage. We examined in-hospital outcomes and resource utilization after thrombolysis in patients with intraventricular hemorrhage requiring ventriculostomy in a real-world setting. METHODS: We identified adult patients with primary diagnosis of nontraumatic intracerebral hemorrhage requiring ventriculostomy from the Nationwide Inpatient Sample from 2002 to 2011. We compared demographic and hospital characteristics, comorbidities, inpatient outcomes, and resource utilization measures between patients treated with IVT and those managed with ventriculostomy, but without IVT. Population estimates were extrapolated using standard Nationwide Inpatient Sample weighting algorithms. RESULTS: We included 34 044 patients in the analysis, of whom 1133 (3.3%) received IVT. The thrombolysis group had significantly lower inpatient mortality (32.4% versus 41.6%; P=0.001) and it remained lower after controlling for baseline demographics, hospital characteristics, comorbidity, case severity, and withdrawal of care status (adjusted odds ratio, 0.670; 95% confidence interval, 0.520-0.865; P=0.002). There was a trend toward favorable discharge (home or rehabilitation) among the thrombolysis cohort (adjusted odds ratio, 1.335; 95% confidence interval, 0.983-1.812; P=0.064). The adjusted rates of bacterial meningitis and ventricular shunt placement were similar between groups. The thrombolysis group had longer length of stay and higher inflation-adjusted cost of care, but cost of care per day length of stay was similar to the non-IVT group. CONCLUSIONS: IVT for intracerebral hemorrhage requiring ventriculostomy resulted in lower inpatient mortality and a trend toward favorable discharge outcome with similar rates of inpatient complications compared with the non-IVT group.
Authors: B M Psaty; T D Koepsell; D Lin; N S Weiss; D S Siscovick; F R Rosendaal; M Pahor; C D Furberg Journal: J Am Geriatr Soc Date: 1999-06 Impact factor: 5.562
Authors: K N Fountas; E Z Kapsalaki; D C Parish; B Smith; H F Smisson; K W Johnston; J S Robinson Journal: South Med J Date: 2005-08 Impact factor: 0.954
Authors: Neal Naff; Michael A Williams; Penelope M Keyl; Stanley Tuhrim; M Ross Bullock; Stephan A Mayer; William Coplin; Raj Narayan; Stephen Haines; Salvador Cruz-Flores; Mario Zuccarello; David Brock; Issam Awad; Wendy C Ziai; Anthony Marmarou; Denise Rhoney; Nichol McBee; Karen Lane; Daniel F Hanley Journal: Stroke Date: 2011-08-25 Impact factor: 7.914
Authors: István Gubucz; Ilona Kakuk; Ottó Major; Norbert Szegedi; Péter Barsi; Gyula Pánczél; Dániel Varga; Csaba Ovary; Zsolt May; Gabriella Ricsói; Júlia Kenéz; Géza Szilágyi; Zoltán Nagy Journal: Orv Hetil Date: 2004-08-01 Impact factor: 0.540
Authors: Daniel Baram; Feroza Daroowalla; Ruel Garcia; Guangxiang Zhang; John J Chen; Erin Healy; Syed Ali Riaz; Paul Richman Journal: Clin Med Circ Respirat Pulm Med Date: 2008-04-18
Authors: Matthew B Maas; Alexander J Nemeth; Neil F Rosenberg; Adam R Kosteva; Shyam Prabhakaran; Andrew M Naidech Journal: Neurology Date: 2013-03-20 Impact factor: 9.910
Authors: Daniel F Hanley; Karen Lane; Nichol McBee; Wendy Ziai; Stanley Tuhrim; Kennedy R Lees; Jesse Dawson; Dheeraj Gandhi; Natalie Ullman; W Andrew Mould; Steven W Mayo; A David Mendelow; Barbara Gregson; Kenneth Butcher; Paul Vespa; David W Wright; Carlos S Kase; J Ricardo Carhuapoma; Penelope M Keyl; Marie Diener-West; John Muschelli; Joshua F Betz; Carol B Thompson; Elizabeth A Sugar; Gayane Yenokyan; Scott Janis; Sayona John; Sagi Harnof; George A Lopez; E Francois Aldrich; Mark R Harrigan; Safdar Ansari; Jack Jallo; Jean-Louis Caron; David LeDoux; Opeolu Adeoye; Mario Zuccarello; Harold P Adams; Michael Rosenblum; Richard E Thompson; Issam A Awad Journal: Lancet Date: 2017-01-10 Impact factor: 79.321
Authors: Santosh B Murthy; Alexander E Merkler; Setareh Salehi Omran; Gino Gialdini; Aaron Gusdon; Benjamin Hartley; David Roh; Halinder S Mangat; Costantino Iadecola; Babak B Navi; Hooman Kamel Journal: Neurology Date: 2017-04-19 Impact factor: 9.910
Authors: Santosh B Murthy; Aditi Shastri; Alexander E Merkler; Daniel F Hanley; Wendy C Ziai; Matthew E Fink; Costantino Iadecola; Hooman Kamel; Babak B Navi Journal: J Stroke Cerebrovasc Dis Date: 2016-08-25 Impact factor: 2.136
Authors: Natalie L Ullman; Pouya Tahsili-Fahadan; Carol B Thompson; Wendy C Ziai; Daniel F Hanley Journal: Neurocrit Care Date: 2019-04 Impact factor: 3.210